Prelude Therapeutics Incorporated
PRLDNASDAQHealthcare● Active
$3.99
+$0.15(+3.91%)
Market Cap$227161780
P/E Ratio—
52W High$5.54
52W Low$0.75
Prelude Therapeutics Incorporated (PRLD) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · PRLD · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $103.21M | $133.61M | $232.94M | $201.73M | $291.23M |
| Net Receivables | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $105.69M | $135.90M | $235.59M | $204.38M | $295.12M |
| PP&E Net | $32.28M | $35.47M | $37.74M | $6.70M | $5.64M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $141.31M | $175.51M | $277.67M | $220.50M | $305.10M |
| Liabilities | |||||
| Short-Term Debt | $2.74M | $0.00M | $0.00M | $0.00M | $0.00M |
| Accounts Payable | $3.98M | $7.73M | $4.58M | $6.78M | $7.84M |
| Total Current Liabilities | $52.99M | $25.64M | $21.83M | $21.70M | $19.20M |
| Long-Term Debt | $15.04M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $72.68M | $44.06M | $40.58M | $25.06M | $19.20M |
| Stockholders Equity | |||||
| Retained Earnings | ($683.06M) | ($583.56M) | ($456.39M) | ($334.56M) | ($219.12M) |
| Total Stockholders Equity | $68.64M | $131.46M | $237.09M | $195.44M | $285.90M |
| Total Liab & Equity(computed) | $141.31M | $175.51M | $277.67M | $220.50M | $305.10M |
| Debt Summary | |||||
| Total Debt | $17.79M | $18.02M | $16.89M | $1.83M | $1.74M |
| Net Debt | ($17.47M) | $5.55M | ($8.40M) | ($28.77M) | ($30.09M) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M
Explore more Prelude Therapeutics Incorporated data
About Prelude Therapeutics Incorporated (PRLD) Balance Sheet
Prelude Therapeutics Incorporated (PRLD) balance sheet shows total assets of $0.14B with cash of $0.10B. Total liabilities are $0.07B, total debt $0.02B, and stockholders equity $0.07B.
Frequently asked questions
PRLD · 4 questionsPrelude Therapeutics Incorporated has total debt of $0.02B with net debt of ($0.02B).
PRLD total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10